medical officer News
-
Anteris appoints Chief Medical Officer
Anteris Technologies Ltd (ASX: AVR) (Anteris or the Company) announces the appointment of the internationally recognized Interventional Cardiologist, Dr Chris Meduri MD MPH, as its Chief Medical Officer (CMO). Dr Meduri is a recognized leader in the field of valvular heart disease, serving as the national principle investigator of several valve trials and on numerous steering committees. He has ...
-
Madeline Griffith of S & G Enterprises Earns Healthcare Scholarship
As the second generation principal of this business – and a proud father – it gives me great pleasure to recognize a third generation associate – and my daughter – Madeline Griffith. Maddie helps in the office with whatever needs doing – but I always knew she was destined for big things. Congratulations to 18-year-old Madeline Griffith, the first recipient of the ...
-
Clearside Biomedical to Present Corporate Overview and Upcoming Catalysts at Eyecelerator at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting
Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will present a corporate overview at the Eyecelerator conference on September 29, 2022, as part of the Annual ...
-
Altimmune to Present Pemvidutide Clinical Data at Upcoming Global NASH Congress May 27, 2022
Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at Altimmune, will give an oral presentation at the 5th Global NASH Congress on May 26-27, 2022, in London, UK. His presentation will provide an overview of pemvidutide, the Company’s novel, investigational GLP-1/glucagon dual receptor agonist under ...
-
Ony Biotech Prepares For The Future
Dr. James Cummings has been an unofficial member of the ONY Biotech family since 1989, when he first started working at the Children’s Hospital of Buffalo. This month, it becomes official, as Dr. Cummings joins the ONY Biotech team as Chief Medical Officer, and the founder of the company and former Chief Medical Officer, Dr. Edmund Egan, steps into the role of Chief Scientific Officer. ...
By ONY Biotech
-
Dr. Dwyer joins Coala Life Inc. as new Chief Medical Officer
Coala Life today is pleased to announce the appointment of Jerome V. Dwyer, MD, MBA as Chief Medical Officer – Coala Life, Inc. Dr. Dwyer will oversee the continued development of Coala’s patient-centric solutions that use smart algorithms to digitally transform the field of cardiac diagnostics and help win the battle against the world’s leading cause of death—heart ...
-
Dr David Dantzker to present Origin’s plasma-generated Nitric Oxide to the MEIDAM dermatology conference in Dubai on September 21, 2019
Origin, Inc., a Phase III clinical-stage biotechnology company, today announced that Dr. David Dantzker, Vice Chairman and Chief Medical Officer of Origin, and former Chairman of the American Board of Internal Medicine, would be presenting Origin’s plasma-generated Nitric Oxide technology to The 4th Middle East International Dermatology & Aesthetic Medicine Conference & Exhibition ...
By Origin, Inc
-
Quarterly Activities Report and 4C Quarterly Cash Flow Report
Botanix (ASX:BOT) has today published its Quarterly Activities Report and 4C Quarterly Cash Flow Report, for the period ended 31 March 2022 Key highlights from this period include: Strategic appointments to Botanix’s executive leadership team,including Dr Patty Walker as Chief Medical Officer and Mr Howie McKibbon as Chief Commercial Officer Danny Sharp also joins as Non-Executive ...
-
Cellphire Therapeutics Appoints Roy A. Beveridge, M.D. to Scientific Advisory Board
Cellphire Therapeutics, Inc., a biotechnology company developing next-generation allogeneic cellular therapeutics for application across multiple medical indications, announced today the appointment of Roy A. Beveridge, M.D. to the company’s Scientific Advisory Board. “Roy is a great addition to our Scientific Advisory Board,” said Mike Gaffney, Chief Executive Officer. ...
-
MODAG Appoints Dr. Johannes Levin as Chief Medical Officer
MODAG today announced the appointment of Johannes Levin, M.D., as Chief Medical Officer (CMO). Dr. Levin brings with him over ten years of experience in the field of movement disorders, particularly in atypical Parkinsonism such as Multiple System Atrophy (MSA), along with a strong scientific background in protein aggregation. He recently led a clinical MSA study with Prof. Dr. Armin Giese, CSO ...
By MODAG GmbH
-
Proprio CMO & Co-founder Dr. Samuel Browd Featured in MedCity News
Proprio’s Chief Medical Officer and Co-founder Dr. Samuel Browd has been published in healthcare industry publication, MedCity News. Dr. Browd’s article, “It’s time to meet the future of the OR: Collaborators”, reinforces the significance of integrating AI into the surgical suite, and the underutilized value in creating interactive partnerships between surgeons, ...
-
Clearside Biomedical to Present at the Ophthalmology Futures Retina Forum 2022
Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer will present a company overview and participate in an industry panel virtually during the Ophthalmology Futures ...
-
Ony Cares For Kids Too
On May 9th, 2019, local radio stations Kiss 98.5 and WBEN hosted the annual Kiss Cares for Kids/ WBEN Radiothon to benefit Oishei Children’s Hospital. The entire radiothon raised over $208,000, surpassing the original $173,000 goal that would enable the hospital to purchase a new ENT Tower. Oishei Children’s Hospital provides state-of-the-art medical care to members of the Buffalo ...
By ONY Biotech
-
Chief Medical Officer and Co-founder Dr. Sam Browd featured in Orthoworld
Proprio Chief Medical Officer & Co-founder Dr. Sam Browd was recently featured in Orthoworld’s “Orthopedics Collecting and Parsing Data in New Ways Via AI” article. Why is AI needed in the orthopedic O.R.? Dr. Browd: The application of artificial intelligence in a clinical setting creates an increased capability to amalgamate highly complex, multidimensional ...
-
Leading clinical immunotherapies developer Ramy Ibrahim joins bit.bio as Chief Medical Officer
biotech firm bit.bio today announces the appointment of Dr Ramy Ibrahim, MD, as Chief Medical Officer. The addition of a Chief Medical Officer is in line with the company’s plans and commitment to transition into a clinical company. Ramy joins from the Parker Institute for Cancer Immunotherapy where he was Chief Medical Officer and will remain on the board. At the Parker Institute, he ...
By bit.bio
-
iSTAR Medical appoints leading glaucoma specialist Prof. Kaweh Mansouri as Chief Medical Officer
WAVRE, Belgium — 6 September 2022: iSTAR Medical, a medtech company delivering breakthrough eye care solutions to patients, today announces the appointment of Dr Kaweh Mansouri as Chief Medical Officer (CMO). Dr Mansouri is a medical and surgical eye specialist, sub-specializing in glaucoma and cataract. Currently a Consultant Ophthalmologist at the Glaucoma Center, Swiss Visio, ...
-
Stephen Hahn, M.D., former U.S. FDA Commissioner, joins YourBio Health as interim Chief Medical Officer
YourBio Health, Inc., developers of the world’s first painless push-button blood collection device, announced today that Stephen Hahn, M.D. joins as interim Chief Medical Officer; he also serves as the Chief Medical Officer, for the Preemptive Medicine and Health Security initiative at Flagship Pioneering at-large. Dr. Hahn previously served as the U.S. Food and Drug Administration ...
-
Results from Orviglance comparison study to gadolinium accepted for oral presentation at the ESGAR confere
Ascelia Pharma AB (publ) (ticker: ACE) today announced that the study where Orviglance was compared against a gadolinium-based contrast agent has been accepted as an oral scientific presentation at the ESGAR conference to be held in May 31 – June 3 in Lisbon, Portugal. “We are very pleased that the study has been selected as an oral scientific presentation at the prestigious ...
-
Orion Biotechnology Presenting New Data at the GPCR Drug Discovery Summit
Orion Biotechnology Canada Ltd, a clinical stage company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs), today announced that it will be presenting important new data at the GPCRs-Targeted Drug Discovery Summit, taking place this week – March 22-24, 2022. Dr. Hartley, Orion’s Vice-President Drug Discovery, will provide a presentation regarding ...
-
Chief Medical Officer and Co-founder Dr. Sam Browd says `Data must enable surgeon performance`
Proprio Chief Medical Officer & Co-founder Dr. Sam Browd was recently mentioned in Orthoworld’s “Orthopedic Enabling Technology Startups Focused on Value” article. “Data is everywhere inside the operating room but has been severely underutilized. We have a huge opportunity to capture it, segment it into strategically informed action and ultimately improve patient ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you